Merck
CN
Search Within

M0194

应用筛选条件
关键词:'M0194'
显示 1-13 共 13 条结果 关于 "M0194" 范围 论文
Stefanie Weber et al.
American journal of human genetics, 89(5), 668-674 (2011-11-15)
Urinary bladder malformations associated with bladder outlet obstruction are a frequent cause of progressive renal failure in children. We here describe a muscarinic acetylcholine receptor M3 (CHRM3) (1q41-q44) homozygous frameshift mutation in familial congenital bladder malformation associated with a prune-belly-like
Masato Asahina et al.
Internal medicine (Tokyo, Japan), 52(24), 2733-2737 (2013-12-18)
The autoimmune mechanism is considered to play an important role in the development of acquired idiopathic generalized anhidrosis (AIGA), and muscarinic M3 receptors (M3Rs) on eccrine glands are possible autoimmune targets. We investigated the existence of autoantibodies against M3Rs in
Muscarinic acetylcholine receptor M3 mutation causes urinary bladder disease and a prune-belly-like syndrome
Weber S, et al.
American Journal of Human Genetics, 89(5), 668-674 (2011)
Frank R Rommel et al.
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 63(5), 329-339 (2015-02-13)
Recent evidence reveals a crucial role for acetylcholine and its receptors in the regulation of inflammation, particularly of nicotinic acetylcholine receptor α7 (Chrna7) and muscarinic acetylcholine receptor 3 (Chrm3). Immunohistochemistry is a key tool for their cellular localization in functional
Overexpression of muscarinic receptor 3 promotes metastasis and predicts poor prognosis in non-small-cell lung cancer
Lin G, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, 9(2), 170-178 (2014)
Muscarinic receptor subtypes and management of the overactive bladder
Chapple C R, et al.
Urology, 60(5), 82-88 (2002)
Chapter 4 - Cholinergic Signaling and Muscle Contraction
Signal Transduction, 11(4), 263-327 (2016)
Javier Milara et al.
Respiratory research, 17(1), 145-145 (2016-11-09)
Inhaled corticosteroid (ICS) with long-acting beta-2 agonists is a well-documented combination therapy for chronic obstructive pulmonary disease (COPD) based on its additive anti-inflammatory properties. By contrast, the recommendation of ICS in combination with long-acting muscarinic antagonist (LAMA) is not evidence-based.
Non-neuronal cholinergic system contributes to corticosteroid resistance in chronic obstructive pulmonary disease patients
Milara J, et al.
Respiratory Research, 17(1), 1-14 (2016)
AUTOANTIBODIES AGAINST MUSCARINIC ACETYLCHOLINE RECEPTOR IN PATIENTS WITH SYNDROME
Autoantibodies, 11(4), 681-685 (2007)
Novel insights into M 3 muscarinic acetylcholine receptor physiology and structure
Kruse A C, et al.
Journal of Molecular Neuroscience, 53(3), 316-323 (2014)
Fine mapping of the body fat QTL on human chromosome 1q43
Aissani B, et al.
Testing, 11(4), e0153794-e0153794 (2016)
Short-term and bystander effects of radiation on murine submandibular glands.
Uchida, et al.
Disease models & mechanisms, 15 (2022)
1/1